Enterprise Financial Services Corp Dexcom Inc Transaction History

Enterprise Financial Services Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $3,841 - $5,154	-36 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $890 - $1,187	-11 Reduced 23.4%	36 $15,000
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $1,017 - $1,256	12 Added 34.29%	47 $17,000
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $955 - $1,129	-10 Reduced 22.22%	35 $14,000
Q2 2020 Aug 04, 2020	BUY	$62.68 - $105.34 $564 - $948	9 Added 25.0%	45 $18,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $191 - $302	4 Added 12.5%	36 $10,000
Q4 2019 Jan 28, 2020	BUY	$36.62 - $57.29 $805 - $1,260	22 Added 220.0%	32 $7,000
Q2 2019 Jul 30, 2019	SELL	$27.84 - $38.92 $334 - $467	-12 Reduced 54.55%	10 $1,000
Q1 2019 Apr 26, 2019	BUY	$28.07 - $38.18 $617 - $839	22 New	22 $2,000
Q4 2017 Jan 26, 2018	SELL	$11.12 - $15.38 $300 - $415	-27 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$11.36 - $18.98 $306 - $512	27	27 $1,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.